Suppr超能文献

特应性皮炎的挑战与未来趋势。

Challenges and Future Trends in Atopic Dermatitis.

机构信息

Department of Dermatology, Seoul St. Mary's Hospital, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.

Gatmaitan Medical and Skin Center, Baliuag 3006, Bulacan, Philippines.

出版信息

Int J Mol Sci. 2023 Jul 12;24(14):11380. doi: 10.3390/ijms241411380.

Abstract

Atopic dermatitis represents a complex and multidimensional interaction that represents potential fields of preventive and therapeutic management. In addition to the treatment armamentarium available for atopic dermatitis, novel drugs targeting significant molecular pathways in atopic dermatitis biologics and small molecules are also being developed given the condition's complex pathophysiology. While most of the patients are expecting better efficacy and long-term control, the response to these drugs would still depend on numerous factors such as complex genotype, diverse environmental triggers and microbiome-derived signals, and, most importantly, dynamic immune responses. This review article highlights the challenges and the recently developed pharmacological agents in atopic dermatitis based on the molecular pathogenesis of this condition, creating a specific therapeutic approach toward a more personalized medicine.

摘要

特应性皮炎是一种复杂的多维相互作用,代表了潜在的预防和治疗管理领域。除了特应性皮炎的现有治疗手段外,鉴于其复杂的病理生理学,针对特应性皮炎重要分子途径的新型药物(生物制剂和小分子药物)也在不断开发中。虽然大多数患者期望获得更好的疗效和长期控制,但这些药物的反应仍取决于许多因素,如复杂的基因型、多种环境触发因素和微生物组衍生信号,最重要的是,动态免疫反应。本文根据特应性皮炎的分子发病机制,重点介绍了特应性皮炎的挑战和最近开发的药理学制剂,为更个性化的医学治疗方法创造了特定的治疗途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b01/10380015/741d392a4150/ijms-24-11380-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验